Evolution of cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis: Are there treatment alternatives?

American Journal of Surgery

Volumn 201, Issue 2, 2011, Pages 157-159

  Sugarbaker, Paul H ^a  

^a WASHINGTON CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

APPENDIX TUMOR; ARTICLE; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CLINICAL TRIAL; COLORECTAL CANCER; CYTOREDUCTIVE SURGERY; HUMAN; HYPERTHERMIC THERAPY; LIVER METASTASIS; MULTIMODALITY CANCER THERAPY; PATIENT SELECTION; PERIOPERATIVE INTRAPERITONEAL CHEMOTHERAPY; PERIOPERATIVE PERIOD; PERITONEUM MESOTHELIOMA; PRIORITY JOURNAL;

EID: 79151474427     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2010.04.010     Document Type: Editorial

References (24)

1. Chua TC, Liauw W, Saxena A, et al. Evolution of loco-regional treatment for peritoneal carcinomatosis: single-centre experience of 308 procedures of cytoreductive surgery and perioperative intraperitoneal chemotherapy. Am J Surg (in press).
2. P. Glasziou, I. Chalmers, and M. Rawlins When are randomised trials unnecessary? Picking signal from noise BMJ 334 2007 349 351
3. P.H. Sugarbaker Epithelial appendiceal neoplasms Cancer J 15 2009 225 235
4. D. Elias, F. Gilly, and F. Boutitie Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study J Clin Oncol 28 2010 63 68
5. T.D. Yan, D. Black, and R. Savady Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma J Clin Oncol 24 2006 4011 4019
6. D. Baratti, S. Kusamura, and A.D. Cabras Lymph node metastases in diffuse malignant peritoneal mesothelioma Ann Surg Oncol 17 2010 45 53
7. P.H. Sugarbaker Five reasons why cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy must be regarded as the new standard of care for diffuse malignant peritoneal Ann Surg Oncol 17 2010 1710 1712
8. J.S. Spratt, R.A. Adcock, and M. Muskovin Clinical delivery system for intraperitoneal hyperthermic chemotherapy Cancer Res 40 1980 256 260
9. R.L. Dedrick Interspecies scaling of regional drug delivery J Pharmacol Sci 75 1986 1047 1052
10. S. Koga, R. Hamazoe, and M. Maeta Treatment of implanted peritoneal cancer in rats by continuous hyperthermic peritoneal perfusion in combination with an anticancer drug Cancer Res 44 1984 1840 1842
11. F.N. Gilly, A.C. Sayag, and P.Y. Carry Intra-peritoneal chemo-hyperthermia (CHIP): a new therapy in the treatment of the peritoneal seedings Preliminary report Int Surg 76 1991 164 167
12. P.H. Sugarbaker Peritonectomy procedures Ann Surg 221 1995 29 42
13. P.H. Sugarbaker, W.J. Cunliffe, and J. Belliveau Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer Semin Oncol 16 1989 83 97
14. D. Elias, F. Gilly, and F. Boutitie Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study J Clin Oncol 28 2010 63 68
15. H.K. Sanoff, D.J. Sargent, and M.E. Campbell Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer; N9741 J Clin Oncol 26 2008 5721 5727
16. R.M. Goldberg, D.J. Sargent, and R.F. Morton Randomized controlled trial of reduced-dose bolus fluorouracil plus leucovorinand irinotecan or infused fluorouracil plus leucovorin and oxaliplatin in patients with previously untreated metastatic colorectal cancer: a North American Intergroup Trial J Clin Oncol 24 2006 3347 3353
17. D. Elias, J.H. Lefevre, and J. Chevalier Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin J Clin Oncol 27 2009 681 685
18. O. Glehen, F. Kwiatkowski, and P.H. Sugarbaker Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study J Clin Oncol 22 2004 3284 3292
19. R.M. Smeenk, V.J. Verwaal, and F.A. Zoetmulder Learning curve of combined modality treatment in peritoneal surface disease Br J Surg 94 2007 1408 1414
20. F. Mohamed, and B.J. Moran Morbidity and mortality with cytoreductive surgery and intraperitoneal chemotherapy The importance of a learning curve Cancer J 15 2009 196 199
21. P.H. Sugarbaker Successful management of microscopic residual disease in large bowel cancer Cancer Chemother Pharmacol 43 Suppl 1999 S15 S25
22. D. Elias, F. Gilly, and F. Boutitie Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study J Clin Oncol 28 2009 63 68
23. L. Bijelic, A. Jonson, and P.H. Sugarbaker Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer Ann Oncol 18 2007 1943 1950
24. C.W. Helm, S.D. Richard, and J. Pan Hyperthermic intraperitoneal chemotherapy in ovarian cancer First report of the HYPER-O registry Int J Gynecol Cancer 20 2010 61 69